Showing 1 - 10 of 3,957
Our calculations indicate that currently proposed U.S. policies to reduce pharmaceutical prices, though particularly beneficial for low-income and elderly populations, could dramatically reduce firms' investment in highly welfare-improving R&D. The U.S. subsidizes the worldwide pharmaceutical...
Persistent link: https://www.econbiz.de/10014576635
Persistent link: https://www.econbiz.de/10010353354
Persistent link: https://www.econbiz.de/10011449900
Persistent link: https://www.econbiz.de/10011456359
Persistent link: https://www.econbiz.de/10011804730
Persistent link: https://www.econbiz.de/10012612575
In this paper, we investigate the problem of estimating distributed lags in short panels. Estimates of the parameter of distributed lag relationships based on single time-series of observations have been usually rather imprecise. The promise of panel data is in the N repetitions of the...
Persistent link: https://www.econbiz.de/10005774662
This paper presents an operational meaning to the concept of the variance in lifetime income in terms of the discounted variance of T mutually uncorrelated, sequentially realized, random variables. It is then shown how the logical implications of the lifecycle consumption model can be used to...
Persistent link: https://www.econbiz.de/10005774948
It is known that innovations in the market value of manufacturing firms and their RhD expenditures are related (Pakes (1985) and Mairesse and Siu (1984)). This could be due to shifts in the demand for the output of a particular firm, to shifts in the technological opportunities available to the...
Persistent link: https://www.econbiz.de/10005777356
In neoclassical models of consumption choice under earnings uncertainty changes in consumption programs from one period to the next are determined by new information received about future earnings over the period. This proposition suggests testing the neoclassical model by ascertaining whether...
Persistent link: https://www.econbiz.de/10005777542